Teladoc Health (NYSE:TDOC) Rating Increased to Buy at Deutsche Bank Aktiengesellschaft

Teladoc Health (NYSE:TDOC) was upgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a research report issued on Tuesday, Marketbeat reports. The brokerage presently has a $11.00 price target on the health services provider’s stock. Deutsche Bank Aktiengesellschaft’s price target indicates a potential upside of 107.35% from the stock’s previous close.

TDOC has been the topic of several other reports. Canaccord Genuity Group cut their price objective on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Bank of America upgraded shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price objective on the stock in a report on Thursday, February 26th. TD Cowen reduced their price target on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Thursday, February 26th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Finally, Stifel Nicolaus decreased their target price on Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a research report on Thursday, February 26th. Six research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Teladoc Health currently has an average rating of “Hold” and an average price target of $7.76.

Teladoc Health Price Performance

TDOC stock opened at $5.31 on Tuesday. The business has a 50 day simple moving average of $5.75 and a 200-day simple moving average of $7.11. The firm has a market capitalization of $946.41 million, a PE ratio of -4.65 and a beta of 2.13. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $9.77. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.77 and a quick ratio of 2.67.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The firm had revenue of $642.27 million for the quarter, compared to the consensus estimate of $635.33 million. During the same period last year, the firm posted ($0.28) EPS. Teladoc Health’s quarterly revenue was up .3% compared to the same quarter last year. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. Equities research analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of Teladoc Health stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total value of $130,762.94. Following the completion of the transaction, the chief executive officer directly owned 201,036 shares of the company’s stock, valued at $1,533,904.68. The trade was a 7.86% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of TDOC. Allianz Asset Management GmbH grew its stake in shares of Teladoc Health by 189.2% in the third quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock valued at $12,518,000 after acquiring an additional 1,059,458 shares in the last quarter. Vanguard Group Inc. grew its stake in Teladoc Health by 4.2% in the 3rd quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider’s stock worth $169,372,000 after acquiring an additional 891,732 shares during the period. Jupiter Asset Management Ltd. acquired a new stake in shares of Teladoc Health during the third quarter worth approximately $7,576,000. Banco Bilbao Vizcaya Argentaria S.A. lifted its position in Teladoc Health by 23.1% in the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 212,933 shares of the health services provider’s stock worth $1,841,000 after buying an additional 39,956 shares in the last quarter. Finally, Empowered Funds LLC bought a new position in Teladoc Health during the second quarter worth about $5,040,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.